MMP9 and psychotic disorder: According to exposing the MMP9 heterozygous mice to psychosis-related locomotor hyperactivity induced by an NMDA receptor antagonist, they also indicated the lower MMP9 level influenced performance in a behavioral model of the positive symptoms of schizophrenia (Lepeta et al., 2017).